A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa.
Viruses
; 13(10)2021 10 18.
Article
in English
| MEDLINE | ID: covidwho-1471001
ABSTRACT
Advances in nanotechnology have enabled the development of a new generation of vaccines, which are playing a critical role in the global control of the COVID-19 pandemic and the return to normalcy. Vaccine development has been conducted, by and large, by countries in the global north. South Africa, as a major emerging economy, has made extensive investments in nanotechnology and bioinformatics and has the expertise and resources in vaccine development and manufacturing. This has been built at a national level through decades of investment. In this perspective article, we provide a synopsis of the investments made in nanotechnology and highlight how these could support innovation, research, and development for vaccines for this disease. We also discuss the application of bioinformatics tools to support rapid and cost-effective vaccine development and make recommendations for future research and development in this area to support future health challenges.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Nanotechnology
/
COVID-19 Vaccines
/
COVID-19
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Humans
Country/Region as subject:
Africa
Language:
English
Year:
2021
Document Type:
Article
Affiliation country:
V13102095
Similar
MEDLINE
...
LILACS
LIS